Innovist revenue FY26: ₹686 Cr
Innovist revenue nearly triples to ₹686 Cr
By Abha Lohia ·
Innovist revenue
Innovist reported revenue of ₹686 Cr in FY26. Reported 20 October 2026.
| Revenue (FY26) | ₹686 Cr |
|---|
Innovist: revenue, valuation and funding and every story →
- Gurugram-based Innovist owns personal care labels including Bare Anatomy, Chemist at Play and SunScoop, sold online and in stores
- Operating revenue reached ₹686 crore in FY26, about 2.8 times the ₹247 crore booked a year before
- L'Oréal bought a majority stake at a valuation near ₹4,100 crore, and the deal closed in October
What happened
- Innovist earned ₹686 crore operating revenue in FY26.
- Last year the figure was ₹247 crore.
- Growth was roughly 2.8 times.
- The jump came before the L'Oréal takeover closed.
- Revenue is said to have risen another 50% from June to October.
Why it matters
- It ranks among the fastest-growing new-age beauty firms.
- Strong numbers backed the ₹4,100 crore valuation.
- It shows buyers want homegrown digital-first brands.
The business
- Innovist is a Gurugram beauty and personal care company.
- It is the parent of Bare Anatomy.
- It also owns Chemist at Play.
- SunScoop is another of its brands.
The founders
RC
Rohit Chawla
Founder and CEOSK
Sifat Khurana
Co-founder and CMOVB
Vimal Bhola
Co-founder and Chief R&D ScientistWho put in money
- L'Oréal Majority owner — French beauty group
In numbers
₹686 CrOperating revenue · FY26
₹247 CrOperating revenue · FY25
Terms in this story
- Valuation: A startup's valuation is the price investors agree the whole company is worth. For young companies it is set by negotiation and comparison, not by a formula.
Everything on Innovist → · All startup news on 20 October 2026 →
Is this Innovist? Get your “Featured on StopDown” badge →